From Wikipedia, the free encyclopedia

Hypothalamic obesity (abbreviated HO or HyOb) is a rare condition that can be congenital or acquired. Congenital causes include Prader-Willi syndrome and mutations of LEP ( leptin gene), LEPR, POMC, MC4R, and CART. It can also result from injuries to the hypothalamus either from trauma, therapeutic radiation, brain surgery, and especially craniopharyngioma and its treatments. Possible treatments include bariatric surgery and melanocortin 4 receptor agonists such as setmelanotide. [1] [2] [3] [4]

References

  1. ^ Dimitri, Paul (6 April 2022). "Treatment of Acquired Hypothalamic Obesity: Now and the Future". Frontiers in Endocrinology. 13: 846880. doi: 10.3389/fendo.2022.846880. ISSN  1664-2392. PMC  9019363. PMID  35464063.
  2. ^ Bereket, A.; Kiess, W.; Lustig, R. H.; Muller, H. L.; Goldstone, A. P.; Weiss, R.; Yavuz, Y.; Hochberg, Z. (September 2012). "Hypothalamic obesity in children". Obesity Reviews. 13 (9): 780–798. doi: 10.1111/j.1467-789X.2012.01004.x. PMID  22577758. S2CID  9550333.
  3. ^ Abuzzahab, M. Jennifer; Roth, Christian L.; Shoemaker, Ashley H. (2019). "Hypothalamic Obesity: Prologue and Promise". Hormone Research in Paediatrics. 91 (2): 128–136. doi: 10.1159/000496564. PMID  30884480. S2CID  83460590.
  4. ^ Kim, Ja Hye; Choi, Jin-Ho (December 2013). "Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents". Annals of Pediatric Endocrinology & Metabolism. 18 (4): 161–167. doi: 10.6065/apem.2013.18.4.161. ISSN  2287-1012. PMC  4027083. PMID  24904871.